Publications by authors named "Peter Pechan"

Claim this Profile
D
Detailed Protocol for the Novel and Scalable Viral Vector Upstream Process for AAV Gene Therapy Manufacturing.
Nagarathinam Selvaraj, Chao-Kuei Wang, Brian Bowser, Trevor Broadt, Samir Shaban, Peter Pechan

Hum Gene Ther· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aurintricarboxylic acid increases yield of HSV-1 vectors.
Peter Pechan, Jeffery Ardinger, Jyothi Ketavarapu, Hillard Rubin, Samuel C Wadsworth

Mol Ther Methods Clin Dev· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene Therapies for Neovascular Age-Related Macular Degeneration.
Peter Pechan, Samuel Wadsworth, Abraham Scaria

Cold Spring Harb Perspect Med· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AAV5-mediated sFLT01 gene therapy arrests retinal lesions in Ccl2(-/-)/Cx3cr1(-/-) mice.
Jingsheng Tuo, Ji-Jing Pang, Xiaoguang Cao, Defen Shen, Jun Zhang, Peter Pechan

Neurobiol Aging· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
sFLT01: a novel fusion protein with antiangiogenic activity.
Rebecca G Bagley, Leslie Kurtzberg, William Weber, Tri-Hung Nguyen, Stephanie Roth, Peter Pechan

Mol Cancer Ther· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of choroidal neovascularization in a nonhuman primate model by intravitreal administration of an AAV2 vector expressing a novel anti-VEGF molecule.
Michael Lukason, Elizabeth DuFresne, Hillard Rubin, Peter Pechan, Qiuhong Li

Mol Ther· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis